Evaluating Rewards-Based Adherence and Electronic Medication Monitoring in HIV-Positive Adolescents
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01849393|
Recruitment Status : Completed
First Posted : May 8, 2013
Last Update Posted : December 16, 2013
|Condition or disease||Intervention/treatment|
|Human Immunodeficiency Virus (HIV) Acquired Immunodeficiency Syndrome (AIDS)||Other: Questionnaire|
|Study Type :||Observational|
|Actual Enrollment :||100 participants|
|Official Title:||Incentives and Technology Survey 2013: Evaluation of Acceptance of Incentive-Based Adherence Programs and Electronic Medication Monitoring Among HIV-Positive Adolescents|
|Study Start Date :||June 2013|
|Actual Primary Completion Date :||December 2013|
|Actual Study Completion Date :||December 2013|
Participants must meet the eligibility requirements will complete a questionnaire on the computer.
Participants who consent to participate in this study will complete a short questionnaire. The survey will be completely anonymous (not matched with the participant's name). Estimated time to complete the survey is 10-20 minutes.
Other Name: Survey
- Reported perceptions about incentive-based adherence programs and electronic medication monitoring [ Time Frame: Once, at enrollment ]Participants will complete a survey/questionnaire on the computer describing their disease state, the frequency and amount of medication taken daily, and how well they comply with taking their medications and attending their clinic appointments. They will also note their perceptions about how incentive-based adherence programs and electronic medication monitoring. Descriptive statistics will be prepared from survey results.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01849393
|United States, Tennessee|
|St. Jude Children's Research Hospital|
|Memphis, Tennessee, United States, 38105|
|Principal Investigator:||Mary Westfall, MD||St. Jude Children's Research Hospital|